Moderna has secured a landmark FDA approval for mFlusiva, its mRNA-based influenza vaccine, marking the first time mRNA technology has been cleared for flu prevention in the United States. The approval covers
British investors are constantly searching for opportunities that deliver returns well above the broader market benchmark, and one UK stock appears to be doing exactly that. The FTSE 100 has long served
MoreThe FTSE 100 is expected to open lower on Monday, with futures pointing to a decline of 19 points, equivalent to a fall of 0.18 per cent. The modest expected drop follows
MoreOmnicare LLC and its parent company CVS Health Corporation have reached a proposed $440 million settlement with the Department of Justice over serious Medicare and Medicaid fraud allegations. The settlement resolves allegations
MoreABC and NBC declined to broadcast Donald Trump’s prime-time speech live, citing concerns that airing election fraud claims in real time would undermine responsible journalism. The refusal angered Trump, who reportedly urged
MoreInvestec has made an immediate impression since its promotion to the FTSE 100, establishing itself as one of the index’s most compelling income stocks. The specialist bank and wealth manager was elevated
MoreThe Monetary Authority of Singapore has tightened monetary policy for the second consecutive time, acting preemptively against a renewed and sharp rise in global oil prices. The MAS said it will increase
MoreExperts are urging governments to shift their focus away from superintelligent AI risks and toward the rapidly growing dangers of AI-enabled warfare. Nicholas Fairfax and Max Rangeley, co-editors of The Artificial Intelligence
MoreOn 3 July 2026, the Department of Justice and the Federal Trade Commission announced they are closely monitoring petroleum markets and gas prices for potentially unlawful conduct. In a joint letter to
MoreThe Trump administration has unveiled a new set of tariffs specifically designed to withstand legal scrutiny following a major setback at the Supreme Court in February. The new duties, ranging from 10%
MoreAnalysts have identified three UK-listed stocks with average 12-month price targets at least double their current share prices, despite the FTSE 100 trading near all-time highs. The three companies span gold mining,
More
